Entering text into the input field will update the search result below

Teleflex' Urolift System shows positive data in five studies to treat enlarged prostate

Jul. 01, 2022 8:55 AM ETTeleflex Incorporated (TFX)By: SA News Team
  • Teleflex (NYSE:TFX) said results from several research studies showed the safety and efficacy of its product, UroLift System, to treat men with enlarged prostate.
  • The company said pooled outcomes of over 300 subjects from five studies revealed most men shifted to lower international prostate symptom score (IPSS) symptom severity after treatment with Prostatic Urethral Lift.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.